Tevogen Inc.

US$5.59As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TVGNHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (60.96%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.23
PE TTM —
TSR TTM (82.21%)
Mkt cap US$87.97M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.52
(1.24%)
(95.85%)
Hold 11|8|1|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.11
0.11
0.11
2.46%
11.02%
8.53%
5.26%
Revenue$M
4.234
4.328
4.531
4.611
4.82%
7.60%
8.58%
13.70%
Peers (US$87.97M)
Cap (US$)
PE
89.01M
131.4x
Capital
TTM
5Y
10Y
Leveragex
0.901
0.105
0.119
EBIT/Intx
2.467
0.259
0.261
Own earn%
33.08
4.38
(10.21)
Sh yield%
23.46
32.87
33.93
Owners
Insiders/Inst%
0.42
44.77
Short interest%
2.33
SBC / revenue%
0.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
6–10
$1 testx
—
Incr. ROIC%
1